CaroGen Company
CaroGen develops vaccine candidates targeting hepatitis B and C, and other viral agents.
Last Funding Type:
Grant
Funding Status:
Seed
Headquarters:
Hamden, Connecticut, United States
Founded Date:
2012-01-01
Last Funding Date:
2019-03-27
Total Funding:
1550000
Employee Number:
1-10
Estimated Revenue:
Less than $1M
Investors Number:
2
Industry:
Viral Vectors